International Prospective Registry on Local Treatment Approaches in MLS

Recruiting now

Conditions studied: Myxoid Liposarcoma

In brief

To prospectively study commonly used local treatment approaches in Myxoid Liposarcoma (MLS)

Key facts

Study ID

NCT04699292

Run by

The Netherlands Cancer Institute

People needed

300

Starts

2021-01-18

Expected to finish

2031-01-01

Last updated by the study team

2022-08-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age > 18 years
• Biopsy proven MLS, including the reciprocal chromosomal translocation t(12;16)(q13;p11)
• ECOG PS 0-2
• Written informed consent to share coded information in this international Registry

You may not qualify if…

• Prior radiotherapy to the target area
• Pregnancy

Where it is running

• The Netherlands Cancer Institute — Amsterdam, Netherlands (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.